Kotler Kevin’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Kotler Kevin’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.94M	Buy	+90,000	New	+$2.91M	0.69%	16

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kotler Kevin's LKFT Position: Q4 2025 in Review

Kotler Kevin opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025: 90,000 shares worth $2.94M. The stake represents 0.69% of the portfolio and ranks #16 among its holdings.

90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

Kotler Kevin held 90,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.94M as of Q4 2025.
Lakefront Biotherapeutics American Depositary Shares was a new Kotler Kevin position in Q4 2025.
Lakefront Biotherapeutics American Depositary Shares made up 0.69% of Kotler Kevin's portfolio in Q4 2025, its #16 holding.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.